Originally meant to address compound medications, the bill has been expanded to create limitations for physician dispensing.
Originally meant to address compound medications, the bill has been expanded to create limitations for physician dispensing.
One bill proposes the use of the ODG guidelines, while another bill would establish a fee schedule similar to neighboring states.
While the report addresses multiple topics, a significant focus was given to the expanding role of pharmacists as a healthcare provider.
The meeting covered potential updates to treatment guidelines, specifically for physical therapy, as well as other topics.
The bill would allow payers to direct prescriptions to pharmacy networks and create limits for physician dispensing and compounds.
New bills would address compounds, deadlines for authorization decisions, and more.
The meeting discussed proton pump inhibitors and the need to review utilization, and future meetings will address GLP-1 drugs, migraine drugs, and more.
Public comments will be accepted on proposed guideline updates until December 19, 2025.
Existing laws and guidelines that refer to CDC guidelines would shift to “nationally recognized clinical practice guidelines.”
Stakeholders provided feedback on the DWC’s proposed rules.
Interested stakeholders must submit written comments by October 28th.
Only 42.8% of injured workers on FRPs had a chronic pain diagnosis, even though clinical guidelines recommend FRPs only for these cases.
The meeting will take place October 2nd and presents an opportunity to influence how topicals are regulated in the state workers’ comp system.
Public comments can be made on the proposed changes until September 26th, at which point a hearing will be held.
Topics covered included recent MTUS updates, the pharmacy fee schedule update, UR and IMR updates, and more.
